Related Experiment Video
Updated: Jul 17, 2026

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test
Published on: April 27, 2016
Contribution of plasma lipid disturbances to vascular endothelial function in patients with slow coronary flow
Alpay Turan Sezgin1, Irfan Barutcu, Nurzen Sezgin
1Department of Cardiology, Baskent University, Practice and Research Hospital, Adana, Turkey.
Insights
Plasma lipid disturbances, particularly low high-density lipoprotein cholesterol (HDL-C) and high triglycerides (TG), are linked to slow coronary flow (SCF). This study found reduced flow-mediated dilatation (FMD) in SCF patients associated with these lipid abnormalities.
Area of Science:
- Cardiology
- Vascular Biology
- Lipid Metabolism
Background:
- Slow coronary flow (SCF) is a microcirculatory abnormality, but its underlying mechanisms remain unclear.
- Previous research suggests a link between microcirculatory dysfunction and lipid disturbances.
Purpose of the Study:
- To investigate the role of plasma lipid disturbances in the pathogenesis of slow coronary flow (SCF).
- To determine the association between lipid profiles and endothelial function in patients with SCF.
Main Methods:
- Cross-sectional study comparing 40 SCF patients with 37 healthy controls.
- Measurement of plasma lipid concentrations (total cholesterol, LDL-C, HDL-C, TG).
- Assessment of brachial artery flow-mediated dilatation (FMD) and nitroglycerin-induced dilatation.
Main Results:
- SCF patients exhibited lower HDL-C and higher TG levels compared to controls.
- Flow-mediated dilatation (FMD) was significantly reduced in SCF patients.
- Plasma HDL-C levels were independently associated with FMD in SCF patients.
Conclusions:
- Plasma lipid disturbances, specifically low HDL-C and high TG, are associated with impaired endothelial function in SCF.
- These findings highlight the potential role of lipid management in addressing slow coronary flow.
Abstract:
Previous studies have suggested that microcirculatory abnormalities cause slow coronary flow (SCF). However, the underlying mechanism of this phenomenon has not yet been well documented. Therefore, the aim of this study was to determine the role of plasma lipid disturbances in pathogenesis of slow coronary flow (SCF). Forty patients with SCF (group I) and 37 subjects with normal coronary arteries (group II) were included in the study. In each subject plasma lipid concentrations (total cholesterol [TC], low-density lipoprotein cholesterol [LDL-C], high-density lipoprotein cholesterol [HDL-C], and triglyceride [TG]) and brachial artery flow-mediated dilatation (FMD) and nitroglycerin (NTG)-induced dilatation were measured. Total cholesterol level was found to be similar in the 2 groups. In group I, HDL-C level was lower than in group II (34 +/-3 vs 40 +/-4 mg/dL, p=0.0001). In group I, TG level was higher than in group II (213 +/-29 vs 198 +/-24 mg/dL p=0.002). In group I, FMD was smaller than that of group II (3.48 +/-3.1% vs 10.4 +/-5.6%, p=0.0001). The percent NTG-induced dilatation was not different between the groups (15.5 +/-5.3% vs 17.3 +/-6.9%, p=0.27). On regression analysis; there was a significant relationship between percent of FMD and HDL-C (r =0.65, p=0.0001). When the 2 groups were analyzed separately, HDL-C was still related to percent of FMD in both groups (r =0.47 p=0.002 and r =0.45 p=0.005, respectively). Multivariate regression analysis showed that only plasma HDL-C was independently related to FMD (F=7.5 p=0.0001). In patients with SCF, reduced flow-mediated dilatation was detected and was found to be associated with plasma lipid disturbances, principally low HDL and high TG levels.
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction
Peripheral Artery Disease I: Introduction
Atherosclerosis I: Introduction
Coronary Artery Disease III: Clinical Manifestations
Atherosclerosis III: Management
